{"company":{"id":3782820,"name":"GentiBio","domain":"gentibio.com","url":"https://alion.io/company/gentibio"},"section":"news","answer":"GentiBio: 6 headlines on record, 1 headline in the last 90 days. Its story counts 4 milestones.","figures":[{"label":"Headlines","value":"6"},{"label":"In 90 days","value":"1"},{"label":"Milestones","value":"4"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":6},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":4}],"news":[{"date":"2026-09-25","kind":"News","title":"BMS adds to IBD pipeline with $1.9bn GentiBio deal","source":"pharmaphorum","url":"https://pharmaphorum.com/news/bms-adds-to-ibd-pipeline-with-1-9bn-gentibio-deal"},{"date":"2026-03-18","kind":"Press release","title":"GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes","source":"PRNewswire","url":"https://prnewswire.com/news-releases/gentibio-announces-first-participant-dosed-in-polaris-phase-1-clinical-trial-of-gnti-122-in-recently-diagnosed-type-1-diabetes-302716586.html"},{"date":"2024-03-22","kind":"News","title":"JCI Insight -GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes","source":"insight.jci.org","url":"https://insight.jci.org/articles/view/171844"},{"date":"2024-03-07","kind":"News","title":"A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells","source":"cell.com","url":"https://cell.com/molecular-therapy-family/molecular-therapy/abstract/S1525-0016(23)00255-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1525001623002551%3Fshowall%3Dtrue"},{"date":"2022-08-10","kind":"News","title":"Immunology startup GentiBio signs $1.9B deal with Bristol Myers","source":"bizjournals.com","url":"https://bizjournals.com/boston/news/2022/08/10/gentibio-bristol-myers-squibb-bms-collaboration.html"},{"date":"2021-08-11","kind":"Press release","title":"GentiBio Announces $157M Series A Financing to Advance Engineered Regulatory T cells as Transformative Therapeutics with Potential to Restore Immune Tolerance and Durably Treat ...","source":"streetinsider.com","url":"https://streetinsider.com/PRNewswire/GentiBio+Announces+%24157M+Series+A+Financing+to+Advance+Engineered+Regulatory+T+cells+as+Transformative+Therapeutics+with+Potential+to+Restore+Immune+Tolerance+and+Durably+Treat+Autoinflammation/18799937.html"}],"story":[{"title":"Won a grant $1.2M · CORDIS","url":"https://www.sbir.gov/awards?keywords=1R44NS145848-01"},{"title":"Won a customer Immunology startup GentiBio signs $1.9B deal with Bristol Myers · bizjournals.com","url":"https://bizjournals.com/boston/news/2022/08/10/gentibio-bristol-myers-squibb-bms-collaboration.html"},{"title":"Raised a round Series A $157M","url":"https://streetinsider.com/PRNewswire/GentiBio+Announces+%24157M+Series+A+Financing+to+Advance+Engineered+Regulatory+T+cells+as+Transformative+Therapeutics+with+Potential+to+Restore+Immune+Tolerance+and+Durably+Treat+Autoinflammation/18799937.html"},{"title":"Website went live first capture in the Wayback Machine","url":"https://web.archive.org/web/20200923042650/gentibio.com"}],"as_of":"2026-11-17","cite":"GentiBio, News. Alion, Nov 17, 2026. https://alion.io/company/gentibio/news","html_url":"https://alion.io/company/gentibio/news","json_url":"https://alion.io/company/gentibio/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T23:02:26Z"}}